Get in touch.

List of contacts

Do you have any questions about ZB MED`s services or the range of literature we offer? Or maybe you need some tips on how to run searches in LIVIVO?

Contact

info@zbmed.de
Phone: +49 (0)221 999 892 240

Cologne Site

Medicine and Health

Address:
ZB MED – Information Centre for Life Sciences
Gleueler Straße 60
50931 Cologne (Köln)
Germany

Bonn Site

Nutritional, Environmental and Agricultural Sciences

Address:
ZB MED – Information Centre for Life Sciences
Friedrich-Hirzebruch-Allee 4
53115 Bonn
Germany

InfoCenter

INFORMATION.

KNOWLEDGE.
LIFE.

An infrastructure and research centre for data and information in the life sciences.

Studying or working in life sciences?

We've got the research tools you need.

Conference detail

Conference details

29.11.2016 - 30.11.2016

6th Munich Biomarker Conference - Clinical Practice and Targeted Therapies in Personalized Medicine

Location
München
Contact

BioM Biotech Cluster Development GmbH

Am Klopferspitz 19a

82152 Martinsried

info@bio-m.org

Country
Germany
Shortinfo

We would like to invite you to the 6th Munich Biomarker Conference to witness how personalized medicine improves health outcomes already today. Recent advances in immunotherapy and combination therapies will be presented. As every year, the meeting highlights latest examples of biomarker discovery, validation and clinical use as well as strategies for biomarker-driven drug development. It will showcase exciting technology developments pushing the boundaries of what is feasible.


Munich is one of Europe’s leading biotech locations with a strategic focus on personalized medicine. BioM, the networking organization for biotechnology in Munich and Bavaria, is organizing the international conference in its sixth year. With the aim to accelerate biomedical innovation, we bring together international experts from biotech and pharma industry with academic scientists and physicians.


We believe that the challenges of future medicine can only be solved by an interdisciplinary approach. On the one hand, biomarker-driven drug development follows common strategies, on the other hand, only joint efforts will transform the health care system. Therefore, the 6th Munich Biomarker Conference is open to various indications, including, but not limited to, oncology, respiratory diseases, immunology and infection, neurological disorders and orphan diseases.